Status:
WITHDRAWN
Utility of Empiric Antibiotics for Non-intubated Novel Coronavirus Diseases 2019 Patients
Lead Sponsor:
National Institutes of Health Clinical Center (CC)
Conditions:
Covid19
Coronavirus Infection
Eligibility:
All Genders
18+ years
Brief Summary
This retrospective analysis of inpatient data obtained from administrative and electronic medical records will investigate the role of empiric antibiotics on admission on the mortality for non-intubat...
Detailed Description
This study will examine the impact of empiric antibiotic therapy on patients who present to hospital with an acute lower respiratory illness and a diagnosis of COVID-19 present-on-admission. The Prem...
Eligibility Criteria
Inclusion
- Adult patients
- Admitted to hospital with International Classification of Diseases Version 10 (ICD-10) diagnosis coding COVID-19 present-on-admission or positive severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) polymerase chain reaction test sampled on admission
- Patients admitted to hospital with ICD-10 diagnosis coding for pneumonia present-on-admission
Exclusion
- Patients with suspected extra-pulmonary bacterial infection
- Patients receiving mechanical ventilation or vasopressors within 48 hours of arrival
- Patients coded as having septic shock present on admission
Key Trial Info
Start Date :
March 1 2020
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
December 31 2023
Estimated Enrollment :
Patients enrolled
Trial Details
Trial ID
NCT04674410
Start Date
March 1 2020
End Date
December 31 2023
Last Update
March 22 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
National Institutes of Health Clinical Center
Bethesda, Maryland, United States, 20892